IPP Bureau
Caplin Steriles gets USFDA approval for potassium phosphates injection
By IPP Bureau - March 14, 2026
Single-use gloves misused across India, raising health risks
By IPP Bureau - March 14, 2026
One task, one interaction, one pair, experts advocate
Aster DM bags overwhelming shareholder backing for merger with Quality Care
By IPP Bureau - March 14, 2026
The endorsement follows overwhelming support for the share swap preceding the merger,
Natural Biogenex joins forces with Fermbox Bio to boost fermentation-based biomanufacturing
By IPP Bureau - March 14, 2026
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
Wanbury bags key Brazil nod, eyes market expansion
By IPP Bureau - March 14, 2026
Pharmaceutical manufacturer Wanbury Limited (WL) has strengthened its position in the Brazilian market after securing regulatory approval for Sertraline Form II from Brazil’s health regulator, ANVISA
Middle East conflict pushes health systems to brink as casualties, displacement surge: WHO
By IPP Bureau - March 14, 2026
The conflict is also triggering a widening public health emergency
Jubilant Ingrevia acquires Remidex Pharma for Rs 16.5 crore
By IPP Bureau - March 14, 2026
Remidex manufactures micronutrient premixes and nutraceuticals,
APL Healthcare’s Unit-IV classified as VAI by the USFDA
By IPP Bureau - March 14, 2026
This inspection is now closed
AI boom, screen overload quietly stealing India’s sleep, new survey warns
By IPP Bureau - March 14, 2026
MetaVia locks down global patent shield for metabolic drug candidate Vanoglipel
By IPP Bureau - March 14, 2026
The protections extend through at least 2035, with the potential for further extensions
Citius Oncology reports promising early trial results for therapy for gynecologic cancers
By IPP Bureau - March 14, 2026
The Phase 1 dose-escalation trial enrolled 25 evaluable patients and was designed to determine the recommended dose of LYMPHIR
Co-Diagnostics bags key Japanese patent, bolstering global push for rapid PCR testing
By IPP Bureau - March 14, 2026
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
WHO Foundation and Novo Nordisk join hands to fight childhood obesity in India
By IPP Bureau - March 14, 2026
The initiative will focus on creating healthier early-life environments, promoting physical activity, identifying risks early, and strengthening preparedness within primary health care systems
Shilpa Biologicals and mAbTree Biologics secure ODD from USFDA
By IPP Bureau - March 13, 2026
Marks significant milestone for breakthrough biologic to treat rare blood cancers
